Велика Британія - англійська - MHRA (Medicines & Healthcare Products Regulatory Agency)

genus pharmaceuticals ltd - indapamide hemihydrate - oral tablet - 2.5mg

Велика Британія - англійська - MHRA (Medicines & Healthcare Products Regulatory Agency)

sigma pharmaceuticals plc - indapamide hemihydrate - oral tablet - 2.5mg

Велика Британія - англійська - MHRA (Medicines & Healthcare Products Regulatory Agency)

rx farma - indapamide hemihydrate - oral tablet - 2.5mg

Нова Зеландія - англійська - Medsafe (Medicines Safety Authority)

viatris limited - lithium carbonate 250mg;  ; lithium carbonate 250mg - film coated tablet - 250 mg - active: lithium carbonate 250mg   excipient: carnauba wax clear film coat 5544 lactose monohydrate magnesium stearate maize starch povidone sodium starch glycolate active: lithium carbonate 250mg excipient: carnauba wax diethyl phthalate ethanol hypromellose e-15 lactose monohydrate magnesium stearate maize starch povidone purified water sodium starch glycolate

Нова Зеландія - англійська - Medsafe (Medicines Safety Authority)

viatris limited - lithium carbonate 400mg;  ; lithium carbonate 400mg - film coated tablet - 400 mg - active: lithium carbonate 400mg   excipient: carnauba wax clear film coat 5544 lactose monohydrate magnesium stearate maize starch povidone sodium starch glycolate active: lithium carbonate 400mg excipient: carnauba wax diethyl phthalate ethanol hypromellose e-15 lactose monohydrate magnesium stearate maize starch povidone purified water sodium starch glycolate

США - англійська - NLM (National Library of Medicine)

direct rx - ofloxacin (unii: a4p49jaz9h) (ofloxacin - unii:a4p49jaz9h) - of the designated microorganisms in the specific conditions listed below: otitis externa in adults and pediatric patients, 6 months and older, due to escherichia coli, pseudomonas aeruginosa, and staphylococcus aureus. chronic suppurative otitis media in patients 12 years and older with perforated tympanic membranes due to proteus mirabilis, pseudomonas aeruginosa, and staphylococcus aureus. acute otitis media in pediatric patients one year and older with tympanostomy tubes due to haemophilus influenzae, moraxella catarrhalis, pseudomonas aeruginosa, staphylococcus aureus,and streptococcus pneumoniae. ofloxacin otic solution 0.3% is contraindicated in patients with a history of hypersensitivity to ofloxacin, to other quinolones, or to any of the components in this medication.

Нова Зеландія - англійська - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - lithium carbonate 250mg - capsule - 250 mg - active: lithium carbonate 250mg excipient: brilliant blue fcf gelatin lactose monohydrate magnesium stearate maize starch quinoline yellow sunset yellow fcf - · treatment of mania and hypomania. · treatment of some patients with recurrent bipolar depression, for which treatment with other antidepressants have been unsuccessful. · prophylactic treatment of recurrent affective disorders.

США - англійська - NLM (National Library of Medicine)

putney, inc. - enrofloxacin (unii: 3dx3xek1bn) (enrofloxacin - unii:3dx3xek1bn) - enrofloxacin 22.7 mg in 1 ml

Нова Зеландія - англійська - Ministry for Primary Industries

randlab australia pty limited - meloxicam - meloxicam 20 g/litre - analgesic

Малайзія - англійська - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

ain medicare sdn. bhd. - levofloxacin hemihydrate -